Dr. Chen is an epidemiologist specializing in human biomarkers of aging. His research spans genomics, epigenetics, transcriptomics, and other molecular biomarkers for prediction, classification, and risk stratification. He currently serves as Chief Science Officer of FOXO Technologies, a publicly traded company that uses epigenetic biomarkers for applications in life insurance. He also holds an adjunct faculty position at UCSD.